Alastair Webb
Overview
Explore the profile of Alastair Webb including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, et al.
Pulm Circ
. 2024 Mar;
14(1):e12337.
PMID: 38500737
Approved therapies for the treatment of patients with pulmonary arterial hypertension (PAH) mediate pulmonary vascular vasodilatation by targeting distinct biological pathways. International guidelines recommend that patients with an inadequate response...
2.
Topiwala A, Mankia K, Bell S, Webb A, Ebmeier K, Howard I, et al.
Nat Commun
. 2023 May;
14(1):2844.
PMID: 37202397
Studies of neurodegenerative disease risk in gout are contradictory. Relationships with neuroimaging markers of brain structure, which may offer insights, are uncertain. Here we investigated associations between gout, brain structure,...
3.
Dawson J, Bejot Y, Christensen L, De Marchis G, Dichgans M, Hagberg G, et al.
Eur Stroke J
. 2022 Sep;
7(3):341-342.
PMID: 36082263
No abstract available.
4.
Akhvlediani T, Gelenidze N, Janelidze T, Gudadze T, Pkhakadze I, Webb A, et al.
Eur Stroke J
. 2022 Sep;
7(3):305-313.
PMID: 36082258
Introduction: We investigated the prevalence, risk factors and physical, mental, and economic consequences of ischemic Janelidze and hemorrhagic stroke in the population of the Republic of Georgia. Materials And Methods:...
5.
Dawson J, Bejot Y, Christensen L, De Marchis G, Dichgans M, Hagberg G, et al.
Eur Stroke J
. 2022 Sep;
7(3):I-II.
PMID: 36082250
Recurrent stroke affects 9% to 15% of people within 1 year. This European Stroke Organisation (ESO) guideline provides evidence-based recommendations on pharmacological management of blood pressure (BP), diabetes mellitus, lipid...
6.
Markus H, van der Flier W, Smith E, Bath P, Biessels G, Briceno E, et al.
JAMA Neurol
. 2022 Aug;
79(11):1187-1198.
PMID: 35969390
Importance: Cerebral small vessel disease (SVD) causes a quarter of strokes and is the most common pathology underlying vascular cognitive impairment and dementia. An important step to developing new treatments...
7.
Webb A, Werring D, Dawson J, Rothman A, Lawson A, Wartolowska K
Eur Stroke J
. 2021 Nov;
6(3):283-290.
PMID: 34746425
Background: Cerebral small vessel disease (SVD) is associated with increased cerebrovascular pulsatility, endothelial dysfunction, and impaired vascular reactivity. Vasodilating phosphodiesterase inhibitors may improve cardiovascular pulsatility and reactivity, and potentially reduce...
8.
Dawson J, Merwick A, Webb A, Dennis M, Ferrari J, Fonseca A
Eur Stroke J
. 2021 Aug;
6(2):VI.
PMID: 34414307
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual...
9.
Dawson J, Merwick A, Webb A, Dennis M, Ferrari J, Fonseca A
Eur Stroke J
. 2021 Aug;
6(2):CLXXXVII-CXCI.
PMID: 34414300
Prevention of early recurrent ischaemic stroke remains a priority in people with TIA or ischaemic stroke. A number of trials have recently been completed assessing the efficacy of short-term dual...
10.
Perry R, Tamborska A, Singh B, Craven B, Marigold R, Arthur-Farraj P, et al.
Lancet
. 2021 Aug;
398(10306):1147-1156.
PMID: 34370972
Background: A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous thrombosis is the most common manifestation of this...